Clinical Trials Logo

Filter by:
NCT ID: NCT05104775 Recruiting - Clinical trials for Hematologic Malignancies

A Study of GNC-035, a Tetra-specific Antibody, in Participants With Relapsed/Refractory Hematologic Malignancy

Start date: February 9, 2022
Phase: Phase 1
Study type: Interventional

In this study, the safety, tolerability and preliminary effectiveness of GNC-035 in patients with relapsed/refractory hematologic malignancies will be investigated to assess the dose-limiting toxicity (DLT), maximum tolerated dose (MTD) or maximum administered dose (MAD) for MTD is not reached of GNC-035.

NCT ID: NCT05104281 Recruiting - Clinical trials for Carcinoma, Non-Small-Cell Lung

Osimertinib Combined With Bevacizumab in Patients With Brain Metastasis Epidermal Growth Factor Receptor (EGFR) Mutation Positive Metastatic Non-Small Cell Lung Cancer

Start date: January 1, 2021
Phase: Phase 3
Study type: Interventional

There is no positive data on osimertinib in the treatment of metastatic EGFR mutation positive non-small-cell lung cancer (NSCLC). The purpose of this study is to study osimertinib combined with bevacizumab in the management of patients with brain metastasis harboring EGFR mutation.

NCT ID: NCT05103813 Recruiting - Clinical trials for Essential Hypertension

Protective Effect of Beraprost Sodium Tablets on Reperfusion Therapy for Acute STEMI

Start date: May 1, 2022
Phase: Early Phase 1
Study type: Interventional

Protective effect of Beraprost Sodium Tablets on coronary microcirculation function and ventricular remodeling after reperfusion therapy for acute ST segment elevation myocardial infarction

NCT ID: NCT05103748 Recruiting - Vertigo Clinical Trials

Function Evaluation of Older Patients With Vertigo and Intervention Study of New Rehabilitation Methods

Start date: July 1, 2021
Phase: N/A
Study type: Interventional

By evaluating the balance, gait and cognitive functions of the elderly patients with vertigo, the relevant functional disorders of the elderly patients with vertigo were clarified, and the functional disorders of the elderly patients with vertigo were improved through the new rehabilitation intervention.

NCT ID: NCT05103345 Recruiting - Clinical trials for Advanced Solid Tumor

Study of SGN1 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumor

Start date: April 19, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

Objectives: To characterize safety, tolerability, MTD and OBD of intratumoral injection of SGN1 in patients with advanced solid tumors, and to preliminarily investigate the efficacy and safety of SGN1 in specific tumor subtypes at OBD doses. Study Rationale: The mechanism of action for SGN1 is based on the fact that most tumors are methionine dependent. SGN1 is designed to be used as a tumor therapeutic bacterium that can preferentially replicate and accumulate in tumors and starve them of essential amino acids by delivering the oncolytic enzyme L-Methioninase. Patient Population: Patients presenting with histologically confirmed advanced and/or metastatic solid tumors that are refractory to standard therapy and for which no other conventional therapy exists.

NCT ID: NCT05103007 Recruiting - Clinical trials for Hepatocellular Carcinoma

PVE/PVL Combined With DEB-TACE in the Treatment of Patients With Large and Unresectable Liver Cancer

CCGLC-004
Start date: December 1, 2021
Phase: N/A
Study type: Interventional

This is a multicenter, randomized, positive parallel controlled clinical study to evaluate the short-term and long-term efficacy and safety of PVL/PVE combined with DEB-TACE in the treatment of unresectable patients with large or large tumors in the right lobe of the liver.

NCT ID: NCT05102448 Recruiting - Takayasu Arteritis Clinical Trials

Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis

Start date: November 1, 2021
Phase: Phase 4
Study type: Interventional

The aim of this study is to evaluate and compare the efficacy and safety of tofacitinib and methotrexate based on prednisone therapy in patients with Takayasu arteritis

NCT ID: NCT05102149 Recruiting - Clinical trials for Type 2 Diabetes Mellitus (T2DM)

Study to Evaluate the Safety and Efficacy of PB-201 in Treatment-naive Patients With Type 2 Diabetes Mellitus

Start date: September 30, 2021
Phase: Phase 3
Study type: Interventional

This is a multicenter, randomized, double-blind, parallel, Vildagliptin and Placebo-Controlled study to evaluate the efficacy and safety of oral administration of 100 mg of PB-201 in the morning and evening in treatmentnaive patients with type 2 diabetes mellitus.

NCT ID: NCT05102006 Recruiting - Clinical trials for Advanced Solid Tumor

Phase Ib/II Clinical Study of LBL-007 in Treatment of Advanced Malignant Tumors

Start date: November 30, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

This trial is a single-arm, open, multi-center phase Ib/II clinical study, which aims to evaluate the safety, tolerability, PK characteristics, immunogenicity, and Effectiveness.

NCT ID: NCT05101772 Recruiting - Pancreas Tumor Clinical Trials

25G and 22G Puncture Needles

Start date: September 24, 2021
Phase:
Study type: Observational

The screened patients were randomly assigned 25G puncture needles and 22G puncture needles in a 1;1 ratio, based on the computer-generated random order, before receiving an ultrasound endoscope puncture. Each puncture needle puncture lesions 2 needles, the same type of puncture needle tissue samples taken in the same tissue pathology bottle, all tissues after the completion of the necessary cytological smears, are placed in the Formalin solution to send tissue pathology, pathologists do not know the order of distribution of 2 puncture needles to evaluate the tissue results, all pathology results are reported by the hospital pathology center, audit.